Blue Ridge Bankshares faces regulatory constraints and lacks a competitive edge in the Virginia banking market, limiting its growth prospects. The bank is exiting its fintech partnerships after an OCC Consent Order, focusing on traditional community banking to reduce risk and improve controls. Despite strong capital ratios, Blue Ridge cannot pay dividends due to regulatory restrictions, and its earnings capacity has declined post-fintech exit.

image for news Blue Ridge Bankshares: Discounted Valuation Is Justified By Fundamental Issues

Circle CEO Jeremy Allaire on Tuesday said he believes the rise of stablecoins won't crowd out lending, but rather that blockchain networks will develop "very robust credit markets."

image for news Circle CEO Jeremy Allaire: We'll see robust credit markets on blockchain networks

Joel Jackson, BMO Capital Markets, joins 'Power Lunch' to discuss Jackson's optimism around Ablemarle, lithium price trends and much more.

image for news BMO's Joel Jackson has a $125 price target on lithium miner Albemarle. Here's why

Weis Markets: A Grocery Stock That's Hard To Justify In Your Cart — Positive

WMK   Seeking Alpha — August 12, 2025

Weis Markets remains a safe, steady, but uninspiring stock, delivering low-single-digit revenue growth and stable margins, but underperforming the S&P. Capital allocation continues to disappoint, with cash used for related-party share buybacks rather than rewarding minority shareholders through dividends or open-market repurchases. Q2 results showed resilient core grocery and pharmacy growth, but margin compression and higher costs weighed on profitability, with little near-term upside expected.

image for news Weis Markets: A Grocery Stock That's Hard To Justify In Your Cart

CoreWeave Inc CRWV has been riding a strong upward current this year, surging more than 250% year-to-date and steadily climbing through the summer months. Now, as it prepares to report second quarter earnings Tuesday, investors are eager to see if this cloud infrastructure leader can keep its bullish streak alive — or if some turbulence lies ahead.

image for news CoreWeave's Chart Looks Bullish — Earnings Could Be The Next Catalyst

'Clock Has Struck Midnight' on Apple's AI Strategy, Dan Ives — Negative

AAPL   Bloomberg Markets and Finance — August 12, 2025

Dan Ives, Global Head: Technology Research at Wedbush Securities, talks about his note on Apple trying to avoid its "Blackberry Moment." Apple's decision to delay its next-generation Siri features this year set off a storm inside the company, leading to executive changes and underscoring to the public just how far behind the company is in artificial intelligence.

image for news 'Clock Has Struck Midnight' on Apple's AI Strategy, Dan Ives

CAVA Group, Inc. CAVA will release earnings results for the second quarter, after the closing bell on Tuesday, Aug. 12.

image for news CAVA Group Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Lumentum Holdings Inc. LITE will release earnings results for the fourth quarter, after the closing bell on Tuesday, Aug. 12.

image for news Lumentum Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Circle CEO Discusses Earnings as Shares Jump — Positive

CRCL   Bloomberg Technology — August 12, 2025

Circle CEO Jeremy Allaire discusses the company's revenue growth and plans to build new products. Shares of the stablecoin issuer jumped following its first earnings report as a public company.

image for news Circle CEO Discusses Earnings as Shares Jump

Circle Internet Group, Inc. CRCL posted stand-out second-quarter financial results on Tuesday in its first earnings report as a publicly traded company.

image for news Circle Stock Pops On Q2 Earnings: USDC Hits $65.2 Billion In Mainstream Stablecoin Adoption

Capital Increase in Genmab as a Result of Employee Warrant Exercise — Neutral

GMAB   GlobeNewsWire — August 12, 2025

Company Announcement COPENHAGEN, Denmark; August 12, 2025 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 4,563 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others.

image for news Capital Increase in Genmab as a Result of Employee Warrant Exercise

Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet — Negative

VRTX   Seeking Alpha — August 12, 2025

A 20% drop in Vertex Pharmaceuticals' stock price since I wrote last month was the impetus to make a re-assessment. But the rating has remained unchanged at Hold. This is despite significantly improved Q2 2025 results, seen in both revenue and non-GAAP earnings' growth, with revenues supported by the likes of Alyftrek and Journavx,. However, an unchanged guidance and disappointing trial outcomes for its investigative pain relief treatment led to a price plunge.

image for news Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet

The Trump administration is still working out the details of its 15% export tax on Nvidia and could bring deals of this kind to more companies, the White House said Tuesday. "Right now it stands with these two companies.

image for news White House says it's working out legality of Nvidia and AMD China chip deals

Cisco Earnings Preview: Stock Price Nearing Its April 2000 All-Time High — Positive

CSCO   Seeking Alpha — August 12, 2025

Analyst consensus is expecting $0.98 in earnings per share on $14.6 billion in revenue as well as 4.97 billion in operating income, for expected year-over-year (y-o-y) growth of 13%, 7% and 14% respectively. Cisco's last big acquisition, Splunk, will now be in Cisco's organic numbers with fiscal Q4 '25. In terms of AI, Cisco appears to have a relatively small AI offering for now, just $1 billion versus the $56–$59 billion in annual revenue, but the AI revenue did look to have beaten expectations in fiscal Q3 '25.

image for news Cisco Earnings Preview: Stock Price Nearing Its April 2000 All-Time High

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap — Positive

COR   Seeking Alpha — August 12, 2025

Cencora delivered strong quarterly results and guidance upgrades, but expectations need to be moderated as these results should fade in the coming quarters. The valuation remains elevated at 17.9x forward P/E, well above the 5-year average, making the risk/reward unattractive at current levels. Key risks include heavy revenue exposure to Walgreens Boots Alliance, which faces solvency issues and plans to sell its COR stake.

image for news Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

TJX to Report Q2 Earnings: Essential Insights Ahead of the Report — Positive

TJX   Zacks Investment Research — August 12, 2025

The TJX Companies rides rising shopper loyalty, strong apparel and home sales, and e-commerce gains, though higher costs and tariffs loom.

image for news TJX to Report Q2 Earnings: Essential Insights Ahead of the Report

PDYN Incurs Q2 Loss Amid Revenue Drop, Contract Slowdown — Negative

PDYN   Zacks Investment Research — August 12, 2025

Palladyne AI incurs a loss in Q2 while its revenues plunge 63% year over year as the company increases investment in AI software commercialization and product development.

image for news PDYN Incurs Q2 Loss Amid Revenue Drop, Contract Slowdown

WILMINGTON, Del.--(BUSINESS WIRE)--Moody's Investors Service has reaffirmed their ratings to WSFS Financial Corporation (NASDAQ: WSFS) (“WSFS” or “the Company”) and WSFS Bank with issuer ratings of Baa2 with a stable outlook. Long-and short-term deposits of A2/Prime-1, together with a standalone Baseline Credit Assessment of Baa1. Moody's has also assigned Counterparty Risk Assessment of A3(cr)/Prime-2(cr) and Counterparty Risk Ratings (local and foreign currency) of Baa1/Prime-2. Moody's debt.

image for news Moody's Reaffirms WSFS Financial Corp's Baa2 Issuer Rating with a Stable Outlook; Reflects Diversified Business Model, Strong Capital, and Earnings Strength

Cardinal Health to Extend Reach by Acquiring Solaris Health — Positive

CAH   PYMNTS — August 12, 2025

Cardinal Health's multi-specialty management services organization (MSO), The Specialty Alliance, plans to acquire urology MSO Solaris Health. Cardinal Health will enable the acquisition by providing about $1.9 billion in cash to The Specialty Alliance and will own about 75% of The Specialty Alliance after the acquisition of Solaris Health, Cardinal Health said in a Tuesday (Aug.

image for news Cardinal Health to Extend Reach by Acquiring Solaris Health

Should You Buy, Sell or Hold MP Stock Post Q2 Earnings Beat? — Positive

MP   Zacks Investment Research — August 12, 2025

MP Materials posts record NdPr output, 84% revenue surge and lands landmark Apple and DoD deals, fueling strong growth prospects.

image for news Should You Buy, Sell or Hold MP Stock Post Q2 Earnings Beat?